On April 1, 2010
Ruling in Genetics Patent Case May Unlock the Code to New Competition
Yesterday, Judge Robert Sweet, a New York district judge, ruled that the patents held by Salt Lake City- based Myriad Genetics on the BRCA1 and BRCA2 genes, which identify a woman’s proclivity to breast and ovarian cancer, are invalid because
…
0 Comments